Aktie A3CNBX BLAU FARMACÊUTICA S.A.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Blau Farmacêutica S.A.

Aktien

A3CNBX

BRBLAUACNOR8

BLAU3

Markt geschlossen - Sao Paulo
Andere Börsenplätze
 22:07:00 28.06.2024 		% 5 Tage % 1. Jan.
10.49 BRL +2.98% Intraday Chart für Blau Farmacêutica S.A. +8.82% -36.08%
08.05. Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024
07.05. Blau Farmacêutica S.A. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Blau Farmacêutica S A : Reunião da Administração
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Blau Farmacêutica S.A. completed the acquisition of Laboratorio Quimico Farmaceutico Bergamo Ltda from Amgen Inc. for $33.2 million.
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
Similis Bio And Blau Farmaceutica Enter Into Development And License Agreement For Biosimilars
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Blau Farmacêutica S A : Dados Econômico-Financeiros
Blau Farmacêutica S.A. announces an Equity Buyback for 4,484,848 shares, representing 2.5% of its issued share capital.
Blau Farmacêutica S.A. authorizes a Buyback Plan.
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CNBX Aktie
  4. Nachrichten Blau Farmacêutica S.A.
  5. Andere Sprachen